![[Translate to Englisch:] (v.l.n.r.) Michael Baumann (DKFZ), Angelika Eggert (Charité Berlin), Rainer Göbel (Moderation), Ulla Ohlms (PATH) und Klaus Schlüter (Vice President MSD SHARP & DOHME) während der Podiumsdiskussion zum Thema Krebsforschung in Deutschland – Überblick/Standort-Bestimmung. © dkfz.de](/fileadmin/_processed_/3/0/csm_Konferenz_Patienten_Partner_Krebsforschung_277ffcc455.jpg "[Translate to Englisch:] (v.l.n.r.) Michael Baumann (DKFZ), Angelika Eggert (Charité Berlin), Rainer Göbel (Moderation), Ulla Ohlms (PATH) und Klaus Schlüter (Vice President MSD SHARP & DOHME) während der Podiumsdiskussion zum Thema Krebsforschung in Deut")
From September 30 to October 2, 2022, the first national conference Patients as Partners...
News
Joint press release by the NCT/UCC Dresden and the NCT Heidelberg
17.08.2022
Patient perspectives closely interlinked: focus areas of the Patient Advisory Board NCT Heidelberg
The Patient Advisory Board is firmly anchored at the NCT Heidelberg. This is also reflected by...
03.05.2022
Therapy for rare cancers: NCT scientists from Heidelberg and Dresden receive the Paul Martini Prize
Joint press release by the NCT Heidelberg and the NCT/UCC Dresden
05.04.2022
Information, support, exchange: Virtual encounters at the 17th Heidelberg CancerPatient Day
On Saturday, April 2, 2022, this year's Heidelberg CancerPatient Day was once again held as a...
23.03.2022
New members in the Managing Directorate
The managing directorate of the National Center for Tumor Diseases (NCT) Heidelberg is expanding...
17.01.2022
NCT Patient Advisory Board reorganized
In November 2021, the NCT Patient Advisory Board at the National Center for Tumor...
01.12.2021
NCT Events: Retrospect 2021
More than 40 events and seminars, around 5,000 participants – in 2021 we were able to offer you...
01.12.2021
Tracking down resistant cancer cells
Press release by the German Cancer Research Center
Corona rapid testing in day clinics 1 and 2 No accompanying persons are...